REVANCE THERAPEUTICS INC shareholders Q3 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
OSAIC HOLDINGS, INC. 4,533$51,9870.00%
WELLS FARGO & COMPANY/MN 35,333$405,2710.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 41,572$476,8310.00%
QUADRANT CAPITAL GROUP LLC 143$1,6410.00%
Legal & General Group Plc 83,300$955,4490.00%
Covestor Ltd 6$00.00%
JANUS HENDERSON GROUP PLC 38,599$442,5400.00%
WOLVERINE ASSET MANAGEMENT LLC 2,200$25,2340.00%
CANADA PENSION PLAN INVESTMENT BOARD 7,700$88,3190.00%
IFP Advisors, Inc 75$8600.00%
Steward Financial Group LLC 4$00.00%
PRICE T ROWE ASSOCIATES INC /MD/ 50,378$5780.00%
NISA INVESTMENT ADVISORS, LLC 695$7,9720.00%
Washington Trust Advisors, Inc. 244$2,7990.00%
AMERIPRISE FINANCIAL INC 125,819$1,443,1440.00%
STRS OHIO 100$10.00%
ALLIANCEBERNSTEIN L.P. 91,000$1,043,7700.00%
TORONTO DOMINION BANK 5$570.00%
DEUTSCHE BANK AG\ 45,042$516,6320.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.